Chromatography Resins Market Size, Share & Industry Analysis, By Type (Ion exchange, Affinity, Multimodal, Size Exclusion, Hydrophobic Interaction, Others), By Application (Pharmaceutical&biotechnology, Water and environmental monitoring, Food & beverage, Others) Others and Regional Forecast, 2024-2032

The chromatography resins market is experiencing growth due to a surge in biosimilar demand and the constant rise in research and development activities within the pharmaceutical and biopharmaceutical industries. This means more biosimilars are being produced and the development of new drugs requires chromatography resins for purification processes. Chromatography is a separation process based on the color of the substrates. Resins play a crucial role in the separation process. They are widely used for separation and purification of the desired substrate such as proteins from the mixture. Analysis of the water sample in various industries is one of the major industrial applications of chromatography where resins have a pivotal role.

Pharmaceutical & biotechnology industries extensively use chromatography resins (in chromatography) for various applications including the production of high purity drugs, monitor & analyze trace contaminants, detection of molecular matter such as vitamins, proteins, fats, and others. To maintain the high quality of products competent to the standards prescribed by the relevant authorities, the choice of chromatographic resins is of high importance to ensure accurate results. Thus, the expansion of the pharmaceutical and biotechnology industries is anticipated to create healthy growth opportunities in the chromatography resins market over the forecast period.

Key Market Driver -

Pharmaceuticals and biotechnology applications to lead the market growth.

Key Market Restraint -

High cost of chromatography resins confine the market growth.

However, the high cost of chromatography resins restricts the market growth. Many end-users tend to opt for alternative analyzing techniques and processes to avoid high expenses. Moreover, certain fixed cost such as membrane, in the column chromatography process for the purification of protein accounts for significant cost, that compels some of the end-users to go for other analyzing and separating techniques.

Chromatography Resins Market Segmentation:

On the basis of type, the chromatography resins market is segmented into ion exchange, affinity, size exclusion hydrophobic interaction, multimodal and others. Based on the applications, the chromatography resins market is classified into pharmaceutical & biotechnology, water, and environmental monitoring, Food & beverage and others.

From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Key Players Covered:

The global chromatography resins industry is fairly fragmented with a number of key players operating in the market. Some of the prominent manufacturers in the global market include

• Bio-Rad Laboratories Inc. 


• Pall Corporation (Danaher)


• Tosoh Corporation


• Mitsubishi Chemical Corporation


• Purolite, Repligen Corporation


• Kaneka Corporation


• Sepragen Corporation


• CHEMRA COMPANY


• Novasep


• JSR Life Sciences


• Others.

Key Insights

• Key Emerging Trends – For Major Regions


• Key Developments: Mergers, Acquisitions, Partnerships, and Others


• Latest Technological Advancement


• Regulatory Landscape


• Porters Five Forces Analysis


• Impact of COVID-19 on the Market

Regional Analysis:

On a geographical basis, the chromatography resins market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounts for the major share in the global market closely followed by Europe and Asia-Pacific. The demand in the region is expected to remain moderate owing to the steady growth of the pharmaceutical & biotechnology industry. Europe is also backed with strong pharmaceutical and biotechnology industries in the world. The pharmaceutical products in Europe are known for their high quality and standards. High quality analyzing techniques including chromatography are responsible for maintaining such high standards, where have a decisive role.

To gain extensive insights into the market, Request for Customization

The market is expected to witness steady growth over the forecast period on the back of developments in the pharmaceutical and biotechnology industries. Asia-Pacific is poised to be the fastest growing region supported by strong growths in developing countries such as China and India. Developed countries such as Japan and South Korea have a healthy demand for chromatography resins. However, major growth opportunities lie in developing countries which are expected to drive the regional markets over the forecast period. Brazil & Mexico drive the market in the Latin America region. The region is expected to witness healthy growth over the forecast period owing to the development of the pharmaceutical industry. However, economic instability in the region is expected to hinder the market growth. Middle East & Africa is a relatively small market. Industrial applications coupled with pharmaceutical & biotech applications drive the market in the region. The political and social unrest such as Libyan crises, Yemen crises, Iran-US conflict, and others, are expected to hamper the market growth over the forecast period.  

Segmentation 

Chromatography Resins Industry Developments

• November, 2019, – Purolite Ltd, a manufacturer of wide range of chromatography resins headquartered in the US, announced that it has started with the commercial production of its Praesto agarose-based chromatography resins.


• October, 2019, – Danaher life sciences, a manufacturer of wide range of products for life sciences applications headquartered in the US, agreed to sell three of its life sciences tool businesses to Sartorius Stedim Biotech, a pharmaceutical & laboratory equipment manufacturer, for USD 750 million cash.


• February, 2019, Danher, announced its plan for the acquisition of boipharm business of GE Life Sciences for around USD 21.4 billion.